Gastroenterology Advisor spoke to Dr. Robert McLean, President of the American College of Physicians (ACP), and Dr. Timothy Wilt, Chair of ACP’s Clinical Guidelines Committee to address several of these questions from the Colorectal Cancer Screening Guidance Statement.
Investigators studied whether colorectal cancer screening rates are influenced by how test options are presented to patients.
Researchers sought to identify missed opportunities for diagnosis of colorectal cancer in primary care that lead to referral delays and emergency diagnoses in younger patients.
Researchers investigated whether increasing colorectal cancer incidence among younger individuals is associated with an increase in disease occurrence or with increased detection as a result of more colonoscopies being performed over time.
Incremental diagnostic yield decreases substantially after 70 to 75 years; LS is rare after 80 years.
Researchers sought to identify the impact NP screening for colorectal cancer using mt-sDNA testing.
Annual nitrate-attributable cases of CRC, ovarian, thyroid, kidney, bladder cancer ranged from 2300 to 12,594.
Neither increases in prevalence of obesity nor heavy alcohol consumption correlated with CRC trends.
Despite overall decline or stabilization, increase seen for young adults in some high-income countries
To determine the effects on colorectal cancer screening response rates, researchers compared various forms of financial incentives with the same monetary value.
